Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective Study of Sonazoid CEUS for Early HCC Surveillance in a High-risk Population

NCT07590284 is registered in ClinicalTrials.gov with Tianjin Third Central Hospital as lead sponsor.

NCT NCT07590284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07590284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective Study of Sonazoid CEUS for Early HCC Surveillance in a High-risk Population
Lead sponsor
Tianjin Third Central Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 30, 2026
Completion date
December 30, 2029
Enrollment
556 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis, liver fibrosis